TTP LabTech has developed both bead- and cell-based fluorescence methods for the screening of antibodies against soluble and cell surface antigens.

Biotech organizations that hire more project managers and fewer programmers, invest in strategic sourcing personnel and adopt risk-based approaches to vendor selection may be better able to adapt to the ever-changing biotech landscape.

Jonathan V. Sweedler is a busy man: he runs a large research group in the Department of Chemistry at the University of Illinois at Urbana-Champaign and is the principal investigator for the UIUC Center for Neuroproteomics on Cell-Cell Signaling and the director of the Roy J. Carver Biotechnology Center.

Rensselaer Polytechnic Institute and principal investigator Glenn Monastersky have been awarded a four-year $2.45 million grant from the New York Stem Cell Science Program (NYSTEM) of the Empire State Stem Cell Board.

The NIH recently published its annual report on funding levels for various research, condition, and disease categories. Since the NIH is a government institution, it should come as no surprise that the biggest changes came in areas that have been the subject of fierce political debate, the most volatile area of which being stem cell research.

Scientists at the U.S. Department of Energys (DOE) Brookhaven National Laboratory have created a new enzyme and demonstrated its potential ability to interfere with the production of lignin, a key cell-wall component in plants.

New approaches promise financial and environmental cost savings while addressing the challenge of increased bio-specimen collection